Pulse Biosciences Inc.

Pulse Biosciences Inc.
Stock Exchange NASDAQ Stock Market
EPS
$2.17
Market Cap
$270.68 M
Shares Outstanding
20.71 M
Public Float
7.92 M

Profile

Address
3957 Point Eden Way
Hayward California 94545
United States
Employees -
Website http://www.pulsebiosciences.com
Updated 07/08/2019
Pulse Biosciences, Inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary Nano-Pulse Stimulation (NPS) technology. It manufactures surgical and medical instruments uses a novel and proprietary platform technology called Nano-Pulse Electro-Signaling. The NPES provides local tumor control and initiates an adaptive immune response with a vaccine-like effect by inducing immunogenic apoptosis of the cells.

Financials

View All

Darrin R. Uecker
President, Chief Executive Officer & Director
Robert W. Duggan
Chairman